Reprogramming of miRNA networks in cancer and leukemia.
By Stefano Volinia, Marco Galasso, S. Costinean, L. Tagliavini, G. Gamberoni, A. Drusco, J. Marchesini, Nicoletta Mascellani, M. Sana, Ramzey Abu Jarour and 41 more. Genome Research, 2010
369 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/8434976c3003bc8e2034c7f9527d7922beffd2f9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Ruth Nussinov
- Peter Csermely
- Huba J. M. Kiss
- Tamás Korcsmáros
- Gabor London
- Alexandre M. J. J. Bonvin
- D. Ritchie
- David Baker
Citations in the corpus
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease (2013, neutral): “We next review the increasing body of literature on the cluster’s oncogenic role (Table 1).(46,47) B-cell Lymphomas”
- MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy (2011, neutral): “However, a detailed analysis of 744 cancer samples identified miR-143∼145 as a commonly deleted cluster, suggesting that the oncogenic roles of this cluster may be the exception rather than the nor”
- Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review (2012, background): “ained from 3312 neoplastic and 1107 nonmalignant human samples showed the dysregulation of hub microRNAs. Cancer-specific microRNA networks had more disjoined subnetworks than those of normal tissues (Volinia et al., 2010). The fast growing complexity of signaling networks still awaits a comprehensiv”